Results 171 to 180 of about 2,468,023 (234)

From Tics to Stabs: Renaming Cluster Tics in Cluster Headache-A Cross-Sectional Study. [PDF]

Eur J Neurol
Carney M, Søborg MK, Maarbjerg S, Lund N, Worm J, Bendtsen L, Jensen RH, Petersen AS.   +7 more
europepmc   +1 more source

Effective Treatment of Refractory Cluster Headache With Propranolol. [PDF]

Cureus
Algahtani R, Basamih K, Aldawsari A, Alyazidi A, Baqadir Y.   +4 more
europepmc   +1 more source

Advanced biomaterials and virtual reality for interventions in rare episodic cluster headache mimicking SUNCT syndrome: emerging directions in precision pain management. [PDF]

Ann Med Surg (Lond)
Ahmed Z, Saifullah M, Khalid M, Talha M, Waafira A.   +4 more
europepmc   +1 more source

Smoking and cluster headache presentation and responsiveness to treatment. [PDF]

BMC Neurol
Hamdy MM, Nasr N, Hamdy E.
europepmc   +1 more source

Current and Novel Therapies for Cluster Headache: A Narrative Review. [PDF]

Pain Ther
de Freitas Dias B, Robinson CL, Villar-Martinez MD, Ashina S, Goadsby PJ.   +4 more
europepmc   +1 more source

Correction: Uncovering drug targets for cluster headache through proteome-wide Mendelian randomization analysis. [PDF]

J Headache Pain
Xiong Z, Guo Z, Zhao L, Qiu D, Mei Y, Li X, Zhang P, Zhang M, Liu G, Gao T, International Consortium for Cluster Headache Genetics, Wang Y, Yu X.   +12 more
europepmc   +1 more source

Uncovering drug targets for cluster headache through proteome-wide Mendelian randomization analysis. [PDF]

J Headache Pain
Xiong Z, Guo Z, Zhao L, Qiu D, Mei Y, Li X, Zhang P, Zhang M, Liu G, Gao T, International Consortium for Cluster Headache Genetics, Wang Y, Yu X.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial

Headache, 2022
Using a patient‐informed regimen, we conducted an exploratory randomized, double‐blind, placebo‐controlled study to systematically investigate the effects of psilocybin in cluster headache.
E. Schindler, R. A. Sewell, Christopher H Gottschalk, Christina Luddy, L. Flynn, Yutong Zhu, H. Lindsey, Brian Pittman, Nicholas V. Cozzi, D. D’Souza   +9 more
semanticscholar   +1 more source

Efficacy and safety of galcanezumab as a treatment of refractory episodic and chronic cluster headache: Case series and narrative review

Headache, 2022
Galcanezumab, a monoclonal antibody targeting calcitonin gene–related peptide (CGRP), has demonstrated clinical benefit as a preventive treatment of episodic cluster headache (ECH) but not in chronic cluster headache (CCH) to this date. Our objective was
J. Membrilla, M. Torres-Ferrús, A. Alpuente, E. Caronna, P. Pozo‐Rosich   +4 more
semanticscholar   +1 more source